naphazoline has been researched along with Prostatic Hyperplasia in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BROSCH, W | 1 |
1 other study available for naphazoline and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Privine instillation into the bladder for prevention of acute urinary retention after endovesical interventions in prostate hypertrophy].
Topics: Abdominal Cavity; Humans; Hypertrophy; Male; Naphazoline; Prostatic Hyperplasia; Sympathomimetics; U | 1956 |